APA (7th ed.) Citation

MY, L., H, L., YC, O., HC, F., EL, S., CH, K., & CH, W. (2025). Comparative effectiveness of paclitaxel versus cyclophosphamide in platinum-based adjuvant treatment of high-risk early-stage epithelial ovarian cancer: An Asian population study. American journal of cancer research, 15(11), 4753. https://doi.org/10.62347/VNGO9832

Chicago Style (17th ed.) Citation

MY, Lin, Lin H, Ou YC, Fu HC, Sung EL, Kao CH, and Wu CH. "Comparative Effectiveness of Paclitaxel Versus Cyclophosphamide in Platinum-based Adjuvant Treatment of High-risk Early-stage Epithelial Ovarian Cancer: An Asian Population Study." American Journal of Cancer Research 15, no. 11 (2025): 4753. https://doi.org/10.62347/VNGO9832.

MLA (9th ed.) Citation

MY, Lin, et al. "Comparative Effectiveness of Paclitaxel Versus Cyclophosphamide in Platinum-based Adjuvant Treatment of High-risk Early-stage Epithelial Ovarian Cancer: An Asian Population Study." American Journal of Cancer Research, vol. 15, no. 11, 2025, p. 4753, https://doi.org/10.62347/VNGO9832.